Literature DB >> 8642452

Changing phosphorus content of the U.S. diet: potential for adverse effects on bone.

M S Calvo1, Y K Park.   

Abstract

The dietary intake of phosphorus in the United States is high relative to calcium. Intake estimates from the 1989-1991 Continuing Surveys of Food Intakes by Individuals conducted by the U.S. Department of Agriculture show that for both men and women, median calcium intakes do not meet the 1989 Recommended Dietary Allowances (RDAs) for most age groups over 10 y of age, whereas phosphorus intakes exceed the RDAs for most age groups. The use of phosphorus-containing food additives in the processing of foods contributes substantially to the daily phosphorus intake, and their use is increasing. Because much of the phosphorus through food additive use is not reflected in the estimates of phosphorus intakes derived from national food consumption surveys, these estimates underestimate true dietary intakes of phosphorus. High phosphorus intake has been shown to cause secondary hyperparathyroidism and bone loss in several animal models. High phosphorus, low calcium consumption consistent with current observed intake levels resulted in changes in calcium-regulating hormones that were not conducive to optimizing peak bone mass in young women. Evidence that such high phosphorus intakes may impair synthesis of the active metabolite of vitamin D and disrupt calcium homeostasis particularly in older women are discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8642452     DOI: 10.1093/jn/126.suppl_4.1168S

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  38 in total

Review 1.  Adolescence: the period of dramatic bone growth.

Authors:  Connie M Weaver
Journal:  Endocrine       Date:  2002-02       Impact factor: 3.633

2.  FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality.

Authors:  Victoria Shalhoub; Edward M Shatzen; Sabrina C Ward; James Davis; Jennitte Stevens; Vivian Bi; Lisa Renshaw; Nessa Hawkins; Wei Wang; Ching Chen; Mei-Mei Tsai; Russell C Cattley; Thomas J Wronski; Xuechen Xia; Xiaodong Li; Charles Henley; Michael Eschenberg; William G Richards
Journal:  J Clin Invest       Date:  2012-06-25       Impact factor: 14.808

Review 3.  Dietary Phosphorus Intake and the Kidney.

Authors:  Alex R Chang; Cheryl Anderson
Journal:  Annu Rev Nutr       Date:  2017-06-14       Impact factor: 11.848

Review 4.  Sodium- and phosphorus-based food additives: persistent but surmountable hurdles in the management of nutrition in chronic kidney disease.

Authors:  Orlando M Gutiérrez
Journal:  Adv Chronic Kidney Dis       Date:  2013-03       Impact factor: 3.620

5.  Dialysis: Dietary phosphorus restriction: changing the paradigm?

Authors:  Lilian Cuppari; Maria A Kamimura
Journal:  Nat Rev Nephrol       Date:  2011-05       Impact factor: 28.314

6.  Associations of socioeconomic status and processed food intake with serum phosphorus concentration in community-living adults: the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Orlando M Gutiérrez; Ronit Katz; Carmen A Peralta; Ian H de Boer; David Siscovick; Myles Wolf; Ana Diez Roux; Bryan Kestenbaum; Jennifer A Nettleton; Joachim H Ix
Journal:  J Ren Nutr       Date:  2012-01-03       Impact factor: 3.655

Review 7.  Inorganic phosphate homeostasis and the role of dietary phosphorus.

Authors:  Eiji Takeda; Hironori Yamamoto; Kunitaka Nashiki; Tadatoshi Sato; Hidekazu Arai; Yutaka Taketani
Journal:  J Cell Mol Med       Date:  2004 Apr-Jun       Impact factor: 5.310

8.  Dietary phosphorus, blood pressure, and incidence of hypertension in the atherosclerosis risk in communities study and the multi-ethnic study of atherosclerosis.

Authors:  Alvaro Alonso; Jennifer A Nettleton; Joachim H Ix; Ian H de Boer; Aaron R Folsom; Aurelian Bidulescu; Bryan R Kestenbaum; Lloyd E Chambless; David R Jacobs
Journal:  Hypertension       Date:  2010-01-18       Impact factor: 10.190

Review 9.  Management of hyperphosphataemia in dialysis patients: role of phosphate binders in the elderly.

Authors:  Víctor Lorenzo Sellares; Armando Torres Ramírez
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

10.  Dietary phosphorus restriction by a standard low-protein diet decreased serum fibroblast growth factor 23 levels in patients with early and advanced stage chronic kidney disease.

Authors:  Shunsuke Goto; Kentaro Nakai; Keiji Kono; Yuriko Yonekura; Jun Ito; Hideki Fujii; Shinichi Nishi
Journal:  Clin Exp Nephrol       Date:  2014-03-01       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.